IMIDAZOCHINOLINE MIT IMMUNMODULIERENDEN EIGENSCHAFTEN

European patent · EP2155743 · Deleted

Register entry

Publication number
EP2155743
Application number
EP08737252
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
May 6, 2008
Published
Feb 24, 2010
Granted
Aug 29, 2012
Deleted
May 31, 2019
Reason
Annual fee unpaid
IPC classes
C07D 471/04 (2006.01)
A61K 31/437 (2006.01)
A61P 37/02 (2006.01)
Priority
US 916586 P 08.05.2007
US 24957 P 31.01.2008
PCT application
PCT/GB2008/050328 06.05.2008
PCT publication
WO2008/135791 13.11.2008
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 18, 2019

    Deleted, fee unpaid

    Published in Swissreg on 18.12.2019

  2. Nov 9, 2016

    Transferred

    Owner
    AstraZeneca AB, 151 85 Södertälje, Sweden, Dainippon Sumitomo Pharma Co., Ltd., 6-8, Dosho-machi 2-chome, Chuo-ku, Osaka-shi, Osaka, Japan → SUMITOMO DAINIPPON PHARMA CO., LTD., 6-8, Dosho-machi 2-chome, Chuo-ku, Osaka-shi, Osaka, Japan

    Published in Swissreg on 09.11.2016

  3. Aug 29, 2012

    Granted

    Published in Swissreg on 29.08.2012

Parties

Inventor

BONNERT, Roger, Victor

Loughborough Leicestershire LE11 5RH, GB

MCINALLY, Thomas

Loughborough Leicestershire LE11 5RH, GB

THOM, Stephen

Loughborough Leicestershire LE11 5RH, GB

WADA, Hiroki

Loughborough, Leicestershire LE11 5RH, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.